Table 1. The correlation between miR-146a expression level and clinicopathological features in the RA patients.
| Group | Case | miR-146a | t | P |
|---|---|---|---|---|
| Gender | 0.479 | 0.642 | ||
| Male | 3 | 1.14 ± 0.11 | ||
| Female | 9 | 1.05 ± 0.31 | ||
| Age | 0.556 | 0.591 | ||
| > 60 years old | 6 | 1.03 ± 0.33 | ||
| ≦ 60 years old | 6 | 1.12 ± 0.22 | ||
| Smoking | 2.326 | 0.042 | ||
| Yes | 3 | 0.81 ± 0.28 | ||
| No | 9 | 1.16 ± 0.21 | ||
| Course of disease | 0.558 | 0.589 | ||
| > 5 years | 7 | 1.04 ± 0.32 | ||
| ≦ 5years | 5 | 1.13 ± 0.19 | ||
| Severity | 9.917 | 0.005 | ||
| Mild | 2 | 1.41 ± 0.07 | ||
| Moderate | 4 | 1.22 ± 0.05 | ||
| Serious | 6 | 0.87 ± 0.22 | ||
| Types of disease activity | 3.682 | 0.004 | ||
| Active stage | 6 | 1.88 ± 0.23 | ||
| Non-active stage | 6 | 1.27 ± 0.12 |
Note: miR-146a: microRNA-146a; Comparisons between two groups were analyzed by t-test. Comparisons among multiple groups were analyzed by one-way analysis of variance (ANOVA).